[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
June 9, 1951


Author Affiliations

Dallas, Tex.

JAMA. 1951;146(6):525-529. doi:10.1001/jama.1951.03670060001001

The over-all salvage rate for bronchiogenic carcinoma remains disappointingly low in spite of advances in its surgical treatment. Pulmonary resections for this neoplasm are now common and can be performed with low morbidity and mortality rates. The disappointing fact is that although surgical removal offers the best treatment available today, it cannot be applied to two thirds of the patients with bronchiogenic carcinoma because the cancer is so far advanced when first seen by the surgeon. The medical profession, having developed an acceptable treatment for cancer of the lung, is now confronted with the problem of its earlier detection in order to make its treatment more effective for the over-all group of persons with this disease.

Recently, we have surveyed our experience during the past three and one-half years with 362 patients having bronchiogenic carcinoma. Of this group, 180, or 50 per cent, were considered clinically inoperable when first seen

First Page Preview View Large
First page PDF preview
First page PDF preview